<DOC>
	<DOCNO>NCT02182843</DOCNO>
	<brief_summary>The purpose study assess clinical radiographic outcome patient undergo ACDF procedure use Cellentra Viable Cell Bone Matrix ( VCBM ) , cortical allograft spacers , MaxAn® Anterior Cervical Plate System . Cellentra VCBM compare publish data autograft NDI ( Neck Disability Index ) improvement radiographic success fusion .</brief_summary>
	<brief_title>Cellentra Viable Cell Bone Matrix ( VCBM ) Anterior Cervical Discectomy Fusion Outcomes Study ( VCBM/MaxAn )</brief_title>
	<detailed_description>This prospective single-arm multi-center study Cellentra Viable Cell Bone Matrix ( VCBM ) MaxAn® Anterior Cervical Plate System use anterior cervical discectomy fusion procedure . This study enroll eighty ( 80 ) subject across eight ( 8 ) clinical site . Subjects recruit pool patient present investigator anterior cervical discectomy fusion procedure .</detailed_description>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>The subject schedule undergo two three level primary spinal fusion surgery level C2T1 ( Cervical 2 Thoracic 1 ) use Cellentra™ VCBM , allograft spacers , MaxAn® Anterior Cervical Plate System . The subject 18 year age old . The subject unresponsive conservative treatment least 6 week unless clinically indicated sooner . The subject persistent neck , shoulder , arm pain consistent cervical degenerative disc disease confirm patient history radiographic study . The subject must investigator 's opinion , psychosocially , mentally , physically able fully comply protocol include require followup visit , fill require form , ability understand give write informed consent . 1 . Subject active local systemic infection . 2 . Subject morbidly obese , define BMI great 40 . 3 . Subject history ( present past ) substance abuse ( recreational drug , prescription drug alcohol ) investigator 's opinion may interfere protocol assessment and/or subject 's ability complete protocol require followup . 4 . Subject inadequate tissue coverage operative site . 5 . Subject open wound local operative area , rapid joint disease , bone absorption , osteopenia , osteomalacia and/or osteoporosis . 6 . Any previous cervical spinal surgery . 7 . Subject condition require medication may interfere bone soft tissue healing ( i.e. , oral parenteral glucocorticoid , immunosuppressive , methotrexate , etc . ) immunocompromised . 8 . Subject medical condition extenuate circumstance , opinion investigator , would preclude participation study . 9 . Subject meet specific indication use Cellentra™ VCBM MaxAn® Anterior Cervical Plate System . 10 . Subject pregnant , lactate interested become pregnant duration study . 11 . Subject currently involve another investigational drug device study could confound study data . 12 . Subject prisoner . 13 . Subject metal sensitivity/foreign body sensitivity . 14 . Subject involved planning engage litigation receive Worker 's Compensation relate neck back pain . 15 . Subject sensitivity allergy process agent . ( See package insert Cellentra™ VCBM ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Cellentra ACDF</keyword>
</DOC>